Volume 44 - Issue 19 - May 8, 2025
State of Kansas
Board of Pharmacy
Notice of Hearing on Proposed Administrative Regulations
A public hearing will be conducted at 8:30 a.m. Thursday, July 10, 2025, at the Board of Healing Arts Conference Room, Lower Level, 800 SW Jackson, Topeka, Kansas, to review and consider the adoption of the proposed permanent regulations of the Kansas State Board of Pharmacy.
This 60-day notice of the public hearing shall constitute a public comment period for the purpose of receiving written public comments on the proposed regulations. All interested parties may submit written comments prior to the public hearing by mail to Alexandra Blasi, Executive Secretary, 800 SW Jackson, Suite 1414, Topeka, KS 66612-1244, or by email to pharmacy@ks.gov. All interested parties will be given a reasonable opportunity to present their views orally regarding the adoption of the proposed regulations during the public hearing. In order to provide all parties an opportunity to present their views, it may be necessary to request that each participant limit any oral presentation to five minutes.
Any individual with a disability may request an accommodation in order to participate in the public hearing and may request the regulations and economic impact statements in an accessible format. Requests for accommodation to participate in the public hearing should be made at least 10 business days in advance of the hearing by contacting Alexandra Blasi, Executive Secretary, 800 SW Jackson, Suite 1414, Topeka, KS 66612-1244 or by phone at 785-296-4056. Handicapped parking is located at the north entrance to the building. Curbs at the north entrance are accessible to individuals with disabilities.
Summaries of the proposed regulations and their economic impacts follow. Copies of the regulations and economic impact statements may be viewed at www.pharmacy.ks.gov/legal/proposed-state-reg-changes.
K.A.R. 68-7-10. Emergency medication kits in long-term care facilities. The proposed amendments split 68-7-10 into two separate regulations to provide clarity and brevity to what 68-7-10 governs: e-kits in long-term care facilities. The Board is also amending 68-7-10 to reflect best pharmacy practices, provide additional clarification that e-kits are only to contain drugs necessary for emergencies, and align with federal law.
The Board anticipates that the amendments will have no identifiable economic impact, and any costs associated with compliance with the regulation should be absorbed within the normal course of business for pharmacies and long-term care facilities.
K.A.R. 68-7-10a. Pharmacy based drug dispensing systems in a facility. The proposed new regulation was previously nested within 68-7-10. Upon reviewing 68-7-10, the Board determined that 68-7-10 actually governed two distinctly different areas of pharmacy practice and that by combining the two, the Board had caused needless confusion. The Board has since split the requirements for “pharmacy based drug dispensing systems in facilities” into the proposed new regulation, 68-7-10a. The Board also took this opportunity to update the language to reflect best pharmacy practices. Finally, the Board removed requirements from the regulation that were needlessly burdensome.
The Board anticipates that the proposed regulation will have no identifiable economic impact, and any costs associated with complying with the regulation should be absorbed within the normal course of business for pharmacies and facilities.
K.A.R. 68-20-32. Revoked. The proposed revocation is due to the regulation’s force and effect having expired; the revocation is merely a formality.
The Board anticipates that the revocation will have no identifiable economic impact.
K.A.R. 68-20-33. Revoked. The proposed revocation is due to the regulation’s force and effect having expired; the revocation is merely a formality.
The Board anticipates that the revocation will have no identifiable economic impact.
K.A.R. 68-21-2. Electronic reports. The proposed amendments allow dispensers that dispense 24-hour supplies to inmates at a correctional institution to request an exemption from subsections (a) and (b) (reporting requirements). K-TRACS does not believe that the aforementioned dispensers need to report, as the risk of diversion, drug abuse, or doctor shopping is nearly non-existent in correctional facilities. This should reduce the burden on those pharmacies.
The Board anticipates that the amendments will have no identifiable economic impact, and any costs associated with complying with the regulation should be absorbed within the normal course of business for pharmacies and correctional institutions.
K.A.R. 68-21-8. Delegates. The proposed regulation expands upon who may be eligible to serve as a delegate. K.S.A. 65-1682 specifies that the Board may authorize individuals to access the program database through rules and regulations. The Board has received requests to allow licensed addiction counselors, licensed clinical addiction counselors, and licensed master’s addiction counselors to access the K-TRACS database. The Board is granting that request through the proposed regulation. The aforementioned individuals working under the authority and supervision of a physician or pharmacist may be granted access to the K-TRACS database as delegates.
The Board anticipates that the proposed new regulation will have no identifiable economic impact, and any costs associated with complying with the regulation should be absorbed within the normal course of business for facilities.
Alexandra Blasi
Executive Secretary
Board of Pharmacy
Doc. No. 053129
